|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation and amortization | |||||
| Amortization of right-of-use assets | |||||
| Originations of loans held for sale | |||||
| Proceeds from loans held for sale | |||||
| Net gain on sale of securities available-for-sale | |||||
| Gain on sale of fixed assets (included in other income) | |||||
| Stock-based compensation | |||||
| Net gain on sale of loans held-for-sale | |||||
| Net amortization of premiums, discounts and loan fees and costs | |||||
| Payments on operating leases | |||||
| Amortization of intangible assets | |||||
| Amortization of debt issuance costs | |||||
| Loan servicing rights valuation adjustments | |||||
| Deferred tax expense | |||||
| Decrease in accrued interest receivable | |||||
| Increase in other assets | |||||
| Increase (decrease) in accrued interest payable | |||||
| (Decrease) increase in other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of securities available-for-sale | |||||
| Purchases of restricted securities | |||||
| Redemptions of restricted securities, net | |||||
| Proceeds from sales of securities available-for-sale | |||||
| Principal repayments of securities held to maturity | |||||
| Maturities, prepayments and calls of securities available-for-sale | |||||
| Proceeds from sales of loans | |||||
| Proceeds from loans held for sale previously classified as portfolio loans | |||||
| Net increase in loans | |||||
| Additions to premises and equipment | |||||
| Proceeds from sales of fixed assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase in deposits | |||||
| Proceeds from term FHLB advances | |||||
| Repayments of term FHLB advances | |||||
| Proceeds from Federal Reserve Bank borrowings | |||||
| Repayments of Federal Reserve Bank borrowings | |||||
| (Repayments) proceeds of other short-term borrowings, net | |||||
| Repayments of other short-term borrowings, net | |||||
| Payments related to tax withholding for equity awards | |||||
| Payments of Ordinary Dividends, Common Stock | |||||
| Net proceeds from issuance of common stock | |||||
| Proceeds from exercise of stock options | |||||
| Cash dividends paid | |||||
| Repurchase of common stock of Hanover Bancorp, Inc. | |||||
| Proceeds from exercise of stock options, net | |||||
| Net cash provided by financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental non-cash disclosure: | |||||
| Transfers from portfolio loans to loans held for sale | |||||
| Transfers from loans to other real estate owned (included in other assets) | |||||
| Preferred stock issued in exchange for common stock | |||||
| Lease liabilities arising from obtaining right-of-use assets | |||||
| Other assets received in satisfaction of a loan | |||||
Loading...